Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

neuroprotective

neuroprotective is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 2
News articles 0
Drug details — neuroprotective
Class
—
Route
—
Patents
20
Programs
2
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

neuroprotective is an FDA-listed pharmaceutical active ingredient.

Key facts

INN neuroprotective

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. DEXMEDETOMIDINE , 18F-DPA-714 Phase 3 · PARItec · Patients who survive a COVID ARDS in intensive care must be
  2. Intra-arterial administration of neuroprotective agents Unknown · Hui-Sheng Chen · Ischemic Stroke

Related patents

Browse patents

  1. US 11974988

    Neuroprotective compositions and methods of using the same

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11970521

    Neuroprotective beta amyloid core peptides and peptidomimetic derivatives

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11872312

    Neuroprotective liposome compositions and methods for treatment of stroke

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11471502

    Neuroprotective peptide

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11414379

    SPAK kinase inhibitors as neuroprotective agents

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11147795

    Neuroprotective compounds and methods of use

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10995061

    SPAK kinase inhibitors as neuroprotective agents

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10973764

    Neuroprotective liposome compositions and methods for treatment of stroke

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10369103

    Neuroprotective liposome compositions and methods for treatment of stroke

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9902713

    Neuroprotective compounds and use thereof

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9645139

    Neuroprotective chemicals and methods for identifying and using same

    Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9243281

    Neuroprotective chemicals and methods for identifying and using same

    Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9205119

    Neuroprotective compositions and methods

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8350077

    Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8329719

    Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

    Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8058268

    Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8030493

    Monovalent and divalent salts of N-(5-hydroxynicotinoil) -L-glutamic acid exhibiting psychotropic (antidepressant and anxiolytic), neuroprotective, geroprotective and cerebroprotective action

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7022882

    NMDA receptor channel blocker with neuroprotective activity

    Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6410537

    Compositions having neuroprotective and analgesic activity

    Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6046200

    Compositions having neuroprotective and analgesic activity

    Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is neuroprotective?

neuroprotective is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.